Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
GRWD1 is a novel histone chaperone that promotes MCM loading and may integrate regulations of cell cycle progression. We identified ribosomal protein RPL11 as a putative GRWD1 binding factor. Under nucleolar stress induced by treatment with low levels of actinomycin D or nutrient deprivation, RPL11 binds to and inhibits the MDM2 ubiquitin ligase, thereby promoting p53 stability. We found that GRWD1 inhibits RPL11-MDM2 interaction, abrogates RPL11-mediated p53 stabilization, and promotes tumorigenesis.
|